Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Jan 24, 2020 4:56pm

130 Views

Post# 30596837

RE:On the bright side - one day and a week close to FDA

Yeah I wonder about that post awhile back when someone warned us when the trump appointed head of the FDA would be biased against companies that weren't of US origin. But it probably is a device specific understanding after all trump doesn't do anything dishonest... wonder if they are capable of blushing when more of their citizens head to good old Canada for our superior treatment hmmmm

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages